Table 1 Demographic and baseline characteristics of study cohort. (categorized by X-tile cutoffs)
Underweight (n = 216) | Normal (n = 968) | Overweight (n = 826) | total | P value | |
|---|---|---|---|---|---|
Age | 65 (59–72) | 63 (57–69) | 64 (57–69) | 63 (58–69) | 0.004 |
Male (%) | 117 (54.2) | 583 (60.3) | 551 (66.7) | 1251 (62.2) | 0.001 |
ALB | 38 (35–42) | 39 (36–42) | 40 (36–43) | 39 (36–42) | 0.001 |
FBG | 5.68 (5.00–6.79) | 6.04 (5.35–7.41) | 6.10 (5.43–7.55) | 6.03 (5.32–7.40) | < 0.001 |
CA199 | 165.3 (37.1–766.9) | 152.2 (39.0–484.6) | 163.8 (41.7–563.7) | 161.1 (40.2–552.2) | 0.34 |
TB | 16.9 (11.4–75.8) | 17.0 (11.3–76.7) | 16.6 (11.8–70.3) | 16.8 (11.6–72.6) | 0.935 |
Biliary drainage (%) | 38 (24.5) | 152 (20.8) | 134 (21.8) | 324 (21.6) | 0.486 |
ASA Score (%) | 0.394 | ||||
1 | 130 (61.6) | 530 (56.5) | 433 (53.9) | 1093 (56) | |
2 | 65 (30.8) | 334 (35.6) | 297 (37) | 696 (35.7) | |
3 | 14 (6.6) | 63 (6.7) | 67 (8.4) | 144 (7.4) | |
4 | 2 (0.9) | 11 (1.2) | 6 (0.7) | 19 (1) | |
Tumor location (%) | 0.495 | ||||
Head | 129 (59.7) | 538 (55.6) | 473 (57.2) | 1140 (56.7) | |
Body/Tail | 87 (40.3) | 430 (44.4) | 353 (42.8) | 870 (43.3) | |
Diagnostic year (%) | 0.758 | ||||
2013 | 9 (4.2) | 35 (3.6) | 32 (3.9) | 76 (3.8) | |
2014 | 19 (8.8) | 57 (5.9) | 56 (6.8) | 132 (6.6) | |
2015 | 22 (10.2) | 105 (10.8) | 80 (9.7) | 207 (10.3) | |
2016 | 30 (13.4) | 146 (15.1) | 137 (16.6) | 313 (15.6) | |
2017 | 48 (22.7) | 199 (20.6) | 149 (18.0) | 396 (19.7) | |
2018 | 47 (21.8) | 205 (21.3) | 174 (21.1) | 426 (21.2) | |
2019 | 41 (19) | 221 (22.8) | 198 (24.0) | 460 (22.9) | |
Stage | 0.162 | ||||
Ia | 17 (8.9) | 88 (9.2) | 87 (10.4) | 192 (9.6) | |
Ib | 48 (22.2) | 222 (22.9) | 208 (25.2) | 478 (23.8) | |
IIa | 19 (8.8) | 72 (7.4) | 64 (7.8) | 155 (7.7) | |
IIb | 59 (27.3) | 248 (25.6) | 225 (27.3) | 532 (26.5) | |
III | 48 (22.2) | 238 (24.6) | 146 (17.7) | 432 (21.5) | |
IV | 25 (11.3) | 100 (10.3) | 96 (11.6) | 221 (11) | |
Differentiation (%) | 0.252 | ||||
I | 0 (0) | 6 (0.6) | 1 (0.1) | 7 (0.3) | |
II | 67 (31) | 325 (33.6) | 258 (31.2) | 650 (32.3) | |
III | 149 (69) | 633 (65.3) | 567 (68.7) | 1349 (67.1) | |
IV | 0 (0) | 1 (0.1) | 0 (0) | 1 (0) | |
Unknown | 0 (0) | 3 (0.3) | 0 (0) | 3 (0.1) | |
Chemotherapy (%) | 93 (43.1) | 57 (56.9) | 500 (60.5) | 1144 (56.9) | < 0.001 |
Surgical interventions (%) | 152 (70.4) | 669 (69.1) | 598 (72.4) | 1419 (70.6) | 0.313 |